The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Sanofi, Vanda, and GSK, a New Year Voyage through the Land of Induced Infringement" on January 21, 2021 from 12:00 pm to 1:00 pm (ET). Tom Irving of Finnegan of Henderson, Farabow, Garrett & Dunner, LLP will moderate a panel consisting of Daniela Gill-Carey of UCB Biopharma, Sarah Hooson of Merck, and Margaret Tomaska of Eli Lilly and Co. The panel will discuss the Federal Circuit decisions in Sanofi v. Watson and Vanda v. Westward, which provide blueprints for possibly obtaining, based on Phase III clinical trial results, many more years of U.S patent exclusivity.
The registration fee for the webinar is $150 for non-members or free for IPO members (government and academic rates are available upon request). Those interested in registering for the webinar can do so here.
Comments